5. What are your immediate goals during this Silicon Valley tenure?
We have three key objectives for our time in Silicon Valley:
Forge strategic partnerships with tech and healthcare leaders.
Attract top US-based talent to strengthen our expertise.
Engage with investors who share our vision for transforming pharmaceutical marketing through AI-driven insights.
Being in the Valley allows us to stay at the cutting edge of AI and healthcare innovation, ensuring that our solutions continue to lead in the industry.
6. How do you envision the future of Talking Medicines in the US?
Our vision is to be an integral part of the US healthcare ecosystem, providing pharma with the most advanced AI-powered intelligence tools to better understand and engage with HCPs and patients. By bridging the gap between real-world experiences and pharma decision-making, we aim to improve patient outcomes and contribute to a more patient-centered healthcare system.